ORIGINAL RESEARCH article

Front. Genet., 14 April 2025

Sec. Human and Medical Genomics

Volume 16 - 2025 | https://doi.org/10.3389/fgene.2025.1558189

Genetic variants in TMPRSS2 influence SARS-CoV-2 infection susceptibility within Mexican Mestizos

Rebeca I. Montero&#x;Rebeca I. Montero1Cinthia L. Dionicio,&#x;Cinthia L. Dionicio1,2Gino NorisGino Noris1Maricela Pia-Pozas,Maricela Piña-Pozas3,4Carla Santana
&#x;Carla Santana1*Rocío Gmez
Rocío Gómez5*
  • 1Biología Molecular Diagnóstica, Querétaro, Qro, Mexico
  • 2Secretaría de Salud, Iguala, Gro, Mexico
  • 3Centro de Información para Decisiones en Salud Pública, Instituto Nacional de Salud Pública (INSP), Mexico City, Mexico
  • 4Centro Cochrane Asociado al INSP, Mexico City, Mexico
  • 5Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico

Since host genetics is one of the primary factors contributing to COVID-19 susceptibility and its clinical progression, several studies have focused on analysing the implications of genetic polymorphisms associated with COVID-19. These studies particularly emphasise on common variants in genes that are involved in the viral mechanism of host entry and in the host’s response to infection. In this study, we explored the participation of 24 single nucleotide polymorphisms located on the ACE, ADAM17, FURIN, IFITM3, TMPRSS2 and VDR genes in SARS-CoV-2 infection susceptibility. Three of these SNPs in TMPRSS2 (rs75603675, OR = 1.86, 95%CI = 1.29–2.66, p ≤ 0.001; rs4303795, OR = 1.98, 95%CI = 1.38–2.84, p ≤ 0.001 and rs8134378, OR = 2.59, 95%CI = 1.28–5.21, p ≤ 0.01) had a significant association with an increased risk of infection. When comparing haplotype frequency distributions, the haplotypes CAG (OR = 7.34, 95%CI = 5.51–9.77), AGA (OR = 2.46, 95%CI = 1.12–5.44), and AGG (OR = 1.59, 95%CI = 1.17–2.16) presented significant associations, suggesting that TMPRSS2 influences SARS-CoV-2 infection susceptibility within Mexican Mestizos. These risk alleles and their haplotypes were found more frequently in the case group than in the reference group, contributing to at least a twofold increase in the risk of SARS-CoV-2 infection, a finding that was reinforced by meta-analyses.

1 Introduction

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was responsible for thousands of deaths worldwide (Zhu et al., 2020; World Health Organisation, 2023). Although a wide range of clinical manifestations and severities (mild, severe and asymptomatic) have been reported, several factors have been associated with COVID-19 morbidity and mortality risk. Male sex and seniors (≥60 years old) have shown significant associations with morbidity and mortality (Hubacek, 2021; Shelton et al., 2021). Pre-existing medical comorbidities such as cardiometabolic disorders, kidney disease, malignancies, and neurodegenerative diseases have also been identified as critical factors influencing the severity of the symptoms and the likelihood of fatal outcomes (Ejaz et al., 2020; Huang et al., 2023).

The genetic background is a significant factor influencing susceptibility to COVID-19, its clinical course, and outcomes (Brest et al., 2020; Ishak et al., 2022; Ceylan, 2020). In this scenario, individuals of African ancestry have demonstrated the highest vulnerability to contracting COVID-19, whereas Asians and Europeans occupy second and third positions, respectively (Hubacek, 2021). Nonetheless, European populations such as Italians and Spanish people were severely affected, even more so than Asians (Ceylan, 2020; Gomez-Mesa et al., 2021; Farooqi et al., 2023). In Latin America, SARS-CoV-2 infection posed a significant public health challenge; this population with an admixed ancestry faced at least three viral infection waves (Gomez-Mesa et al., 2021; Santoro et al., 2022). According to data from March 2023, Mexico ranked 12th worldwide in confirmed COVID-19 cases, with over seven million reported cases (https://coronavirus.jhu.edu/map.html). Latinos, who exhibit notable susceptibility to the virus, serve as a genetic reservoir of these ancestral legacies (European, Asian, and African) (Sutton et al., 2022; Alvarez-Topete et al., 2024; Gomez et al., 2021; Santana et al., 2014). Latino populations are particularly young, with at most twenty generations. Consequently, their genetic architecture could present interethnic variations, creating an ideal context to explore the role of ethnic background in disease predisposition (Brest et al., 2020; Ishak et al., 2022).

Different polymorphic gene variants have been analysed concerning COVID-19 susceptibility, and several studies have focused on common variants associated with the risk of infection from other respiratory viruses (Cheng et al., 2015; David et al., 2022; Posadas-Sanchez et al., 2022). Additionally, other studies have highlighted the relationship between blood type and ancestry in the differential risk among populations (Shelton et al., 2021). In this context, the Genome Aggregation Database has reported that certain variants related to the severity of COVID-19 clinical manifestations exhibit high frequencies within European and African populations (Niemi et al., 2022). Despite the diverse genetic makeup of Latino populations, there is a limited number of studies addressing the influence of ethnic background and the distribution of the genetic variants in the function of SARS-CoV-2 infection susceptibility.

In the present study, we evaluated the association of 24 single nucleotide polymorphisms located in the ACE2, ADAM17, FURIN, IFITM3, TMPRSS2, and VDR genes with SARS-CoV-2 infection susceptibility in 489 Mexican Mestizos (case and reference groups) residing in Queretaro. Allele, genotype and haplotype analyses were conducted in our target population as in those populations that contributed to its genetic background; meta-analyses further supported our findings.

2 Materials and methods

2.1 Genes and single nucleotide polymorphisms selection

We selected 24 single nucleotide polymorphisms (SNPs) located in the ACE2, ADAM17, FURIN, IFITM3, TMPRSS2, and VDR genes (Supplementary Table S1). The selection of genes was based on previous reports regarding virus entry mechanisms, respiratory illnesses, and in silico experiments; all genetic variants exhibited frequencies ≥1% in the 1000 Genomes Project database (1KGP; https://www.internationalgenome.org/).

2.2 Studied groups characteristics

A convenience sampling cross-sectional study was conducted from August 2020 to July 2021 involving unrelated individuals (no parent, grandparent, sibling, uncle or cousin of the participants were involved) who visited the Biología Molecular Diagnóstica (BIMODI) Laboratory to undergo SARS-CoV-2 testing. BIMODI fullfilled all requirements to process SARS-CoV-2 samples as endorsed by the Institute of Diagnosis and Epidemiological Reference from Mexico (InDRE, acronym in Spanish). Inclusion criteria considered for both the case and reference groups were: males and females self-identified as Mexican Mestizos with four grandparents born in Mexico, who completed a questionnaire and signed an informed consent form. Pregnancy and breastfeeding were used as exclusion criteria because these physiological states alter the immune system, representing a possible change in susceptibility to infections. The cases were individuals who tested positive for SARS-CoV-2 identified through the analysis of nasopharyngeal swabs using real-time reverse transcription polymerase chain reaction (RT-PCR). A total of 241 adults were enrolled as cases, 107 men and 134 women; age mean and standard deviation: 40 ± 14 years (residing in Santiago de Querétaro, a Central Valley of Mexico state located 213 km northwest of Mexico City). In such individuals, the prevalence of COVID-19 comorbidities was assessed using a questionnaire. The population reference allele frequencies were determined from a DNA bank of individuals who visited the laboratory before the SARS-CoV-2 pandemic, reflecting the ethnic and socioeconomic characteristics of the population that BIMODI laboratory attends for routine clinical check-ups. This group was populational-based (124 men and 124 women) and consisted of unrelated individuals. Such particularities minimised potential bias related to increased resistance or susceptibility to SARS-CoV-2 infection, which could exist if never-infected individuals had been included as a control. Cases were paired by sex with the reference group.

An internal Ethics Committee composed of external researchers approved protocol BMD-DI-2020-001 and the sample collection. The present study was conducted in accordance with the principles established by the Declaration of Helsinki.

2.3 Sample collection and molecular analyses

Samples for SNP genotyping were obtained from peripheral blood leukocytes using the BD Vacutainer system (Becton Dickinson, Franklin Lakes, NJ, United States) using EDTA as anticoagulant and DNA was isolated from the buffy coat with QIAamp® DNA Mini Kit (QIAGEN, Venlo, NLD) using the QIAcube automated sample preparation (QIAGEN, Venlo, NLD). In some cases, SNP genotyping was made from genomic material isolated from the nasopharyngeal swab taken for the SARS-CoV-2 test using Quick RNA Viral Kit (Zymo Research, Irvine, CA, United States).

Real-time Polymerase Chain Reaction (qPCR) was used to quantify the genetic material with a Quant Studio™ 7 Real-Time PCR System (Applied Biosystems, Waltham, MA, United States) using 348 plates following conditions recommended by the manufacturer. Allelic discrimination of SNPs was conducted by qPCR using Master kit GoTaq® 1 Step RT-qPCR System (Promega, Madison, WI, United States), and TaqMan® assays (Supplementary Table S1) (Applied Biosystems, Waltham, MA, United States) in the Quant Studio™ 7 Real-Time PCR System (Applied Biosystems, Waltham, MA, United States). The thermal cycling conditions for TaqMan® assays were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 1 min. The genotyping process was conducted in a double-blinded manner for the analyst.

2.4 Statistical analyses

2.4.1 Genetic analyses

Allelic, genotypic, and haplotypic frequencies, as well as observed (Ho) and expected (He) heterozygosity, and the analysis of molecular variance (AMOVA) were estimated with Arlequin v3.5 (Excoffier and Lischer, 2010). Linkage disequilibrium (LD) likelihood estimations of the analysed SNPs was carried out using their genetic position and genotypes reported in the 1KGP database (https://www.internationalgenome.org/). The LD heat map was obtained using the online platform for data visualisation SRplot (Tang et al., 2023). Weir and Cockerham’s F statistics were used to determine the Hardy-Weinberg expectation (HWE) with Genètix v4.05.2 (Belkhir et al., 2004). Genetic distances (FST) among the explored groups were also calculated with Arlequin v3.5 using 1,000 permutations and visualised with a multidimensional scaling (MDS) plot with the Statistical Package for Social Sciences (SPSS) v23 (IBM Corp., Armonk, NY, United States). All p values were adjusted for false discovery rates (FDR) (Benjamini and Hochberg, 1995). Haplotype networks were constructed using Median-Joining (MJ) with Populational Analysis with Reticulate Trees (PopART) (Leigh and Bryant, 2015).

2.4.2 Comparison with other populations

The diversity patterns obtained were compared with those populations that historically contributed to the genetic background of the Mexican Mestizo. Data from African (AFR), East Asian (EAS), and European (EUR) populations, as well as Mexican Ancestry in Los Angeles, California (MXL) was obtained from the 1KGP database (https://www.internationalgenome.org/). Additionally, our data was also compared with other Latin American populations, including Colombians in Medellin (CLM), Puerto Ricans in Puerto Rico (PUR), and Peruvians in Lima (PEL).

2.4.3 Associations with SARS-CoV-2 infection susceptibility

Case and reference groups were compared; depending on the variable type and distribution, Student’s t-test, χ2 test, or Fischer exact test were employed. The genetic association with SARS-CoV-2 infection susceptibility was estimated with an unconditional logistic regression model. The age at the time of the interview was included as a continuous variable. Measures of gene variant effects were determined through odds ratio (OR). Analyses were performed using statistical software STATA v14 (StataCorp LP, College Station, TX, United States). In those SNPs where associations with the SARS-CoV2 susceptibility were identified in allele and genotype comparisons, further analyses were conducted using dominant and recessive models.

2.4.4 Genetic comparisons with previous reports: Meta-analyses of SARS-CoV-2 infection susceptibility

The effects of our findings were also combined with results obtained from other publications. Measures of gene variant effects were estimated by comparing frequency differences between cases and the reference group. Meta-analyses were performed with the web-based app MetaGenyo (Martorell-Marugan et al., 2017). Subgroup analyses were performed using the web-based app Meta-analysis made easy developed with Shiny using the R packages meta and metafor (Viechtbauer, 2010). Heterogeneity among the included studies and the data obtained from the present study was determined with the heterogeneity index (I2). Values greater than or equal to 25%, 50%, and 75% were classified as low, moderate and high heterogeneity, respectively. If heterogeneity was ≥25%, the random effects model was applied, and the DerSimonian and Laird method was used as the weight method; otherwise, the fixed effects model was used, and the inverse of variance was used as the weight method. All results were summarised with forest plots using the statistical Mantel-Haenszel method to analyse the effect size from the combined results of the various studies included.

3 Results

The case group exhibited the following prevalence of comorbidities relevant to COVID–19 development: diabetes (7%), hypertension (9%), cardiovascular diseases (2%), smoking (24%), obesity (24%), and asthma (2%). This population was distributed in the following age groups: 0–14 years (1%), 15–24 years (9%), 25–34 years (28%), 35–44 years (24%), 45–54 years (22%), >55 years (16%). The sex distribution was as follows: female (55%) and male (45%). The reference group was chosen to have the same sex distribution, but the distribution of its comorbidities is unknown.

The allele and genotype frequencies obtained from all analysed polymorphisms are shown in Table 1; Supplementary Table S2, S3. Individually and collectively, all SNPs exhibit Hardy-Weinberg equilibrium in cases (FIS = −0.014, p = 0.826) and the reference group (FIS = 0.044, p = 0.005) with a nuanced heterozygous and homozygous excess, respectively; the p-value applying Bonferroni’s correction was 0.003. AMOVA test exhibits an irrelevant variance (0.004) among populations (cases versus reference group), with the variation within populations as the main source of variance (0.996, p = 0.003).

Table 1
www.frontiersin.org

Table 1. Allele, minimum allele, genotype frequencies and equilibrium regarding the Hardy-Weinberg equation in the seven TMPRSS2 polymorphisms.

3.1 TMPRSS2 polymorphisms were associated with SARS-CoV-2 susceptibility

Out of the 24 explored polymorphisms (Supplementary Table S1), only some of them in the TMPRSS2 gene were associated with the risk of infection with SARS-CoV-2 (Figure 1; Supplementary Figure S1). Most of these SNPs were in LD (p ≤ 0.0001; Figure 2). Four of them (rs61735794, rs75603675, rs4303795, and rs8143478) were linked to an increased susceptibility to SARS-CoV-2 infection (Figure 1), exhibiting significant differences in allele and genotype frequencies between the case group and the reference one (Table 1). Nonetheless, the results for rs61735794 should be interpreted with caution due to the wide confidence interval and because the p-value was not significative (OR = 4.77; 95%CI = 1.02–22.32, p ≥ 0.05); rs456298, rs2070788 and rs12329760 show marginal associations (Figure 1).

Figure 1
www.frontiersin.org

Figure 1. Plot summarising the risk alleles and the odds ratios obtained from allele and genotype comparisons between the case and reference groups for the seven TMPRSS2 polymorphisms explored using several genotype models. Footnote: The dominant and recessive combinations conducted were: rs4562985Dominant = AA + AT versus TT, rs4562985Recessive = AA vs. AT + TT; rs20707885Dominant = AA + AG vs. GG, rs20707885Recessive = AA vs. AG + GG; rs61735794Dominant = TT + TC vs. CC, rs61735794Recessive = TT vs. TC + CC; rs12329760Dominant = TT + TC vs. CC, rs12329760Recessive = TT vs. TC + CC; rs75603675Dominant = AA + AC vs. CC, rs75603675Recessive = AA vs. AC + CC; rs4303795Dominant = GG + GA vs. AA, rs4503795Recessive = GG vs. GA + AA; rs8134378Dominant = AA + AG vs. GG, rs8134378Recessive = AA vs. AG + GG.

Figure 2
www.frontiersin.org

Figure 2. Linkage disequilibrium heatmap on the reference group based on the genetic distances among the several polymorphisms studied in TMPRSS2 gene. Note: The intensity of the colours means the closeness between the SNPs and, in turn, their linkage disequilibrium.

Thus, subsequent analyses focused on the three polymorphisms (rs75603675, rs4303795 and rs8134378) with a significant association; the alleles A, G, and A were identified as risk alleles, respectively. In the context of the genotypic state, specific distributions were observed (Table 1). The most common genotype of rs75603675 was CC in cases and the reference group. Regarding the frequency distribution of rs4303795, the heterozygous state (AG) was more prevalent in the case group (0.480) than in the reference group (0.360), where the AA genotype presented the main frequency (0.610). In cases and the reference group, the most common genotype for rs8134378 was GG. In terms of each variant´s infection risk using the random model (Figure 1), rs75603675 had the lowest association (OR = 1.86; 95%CI = 1.29–2.66, p = 0.001), followed by rs4303795 (OR = 1.98; 95%CI = 1.38–2.84, p ∼ 0.0003); and rs8134378 exhibited the highest association (OR = 2.59; 95%CI = 1.28–5.21, p = 0.010).

3.2 Comparisons of TMPRSS2 haplotypes between the selected populations

Having demonstrated the contribution of these three SNPs (rs75603675, rs4303795, and rs8134378) and the LD among them, haplotypes were constructed. Such haplotypes are presented in the same SNPs’ order. Out of eight possible combinations, seven were identified within the analysed groups. Of these, the haplotype CAG (OR = 7.34; 95%CI = 5.51–9.77, p < 0.0001) presented the strongest association, followed by AGA (OR = 2.46; 95%CI = 1.12–5.44, p = 0.03), and AGG (OR = 1.59; 95%CI = 1.17–2.16, p = 0.004). Such haplotypes were compared with those obtained from the 1KGP populations. Both cases and the reference group exhibited significant and no significant differences with EUR and MXL, respectively (Figure 3A). The MJ network show the remarkable prevalence of the CAG, AGG and AGA haplotypes across the compared populations (Figures 3A, B). It is important to highlight the remarkable prevalence of these haplotypes, as well as AAG, among Europeans, the high distribution of the CAA haplotype in the case group, and CGA in the studied groups. Comparisons with the remaining Latin American populations from 1KGP revealed a strong connection between MXL and PEL, although this data is not presented.

Figure 3
www.frontiersin.org

Figure 3. Bar plot with the statistical differences (A), median-joining network (B), and multidimensional scale plot of FST values (C), of haplotypes found in the case and reference groups and their comparisons with two populations from the one thousand genome project. Note: MXL, Mexican in Los Angeles, California; EUR, European populations. The alleles of the SNPs conforming to the haplotype are shown in the following order: rs75603675, rs4303795, rs8134378.

Although the case and reference groups exhibit a modest genetic distance to MXL (FST < 0.05), indicating that both groups belonged to the same population (p ≥ 0.05), significant differences were observed between cases and the reference group (FST = 0.2684, p ≤ 0.0001). Genetically, the case group was four times closer to EUR (FST = 0.01776) than the reference group (FST = 0.08148) and almost twice than MXL (FST = 0.03018). This finding was further supported by the MDS plot (stress value ∼0.0008), showing the genetic relationship between EUR and the case group, distinguishing them from the MXL and the reference group (Figure 3C). Nonetheless, the genetic distances between the studied groups and EUR were statistically significant (Supplementary Table S4).

3.3 Meta-analyses support TMPRSS2 association with SARS-CoV-2 susceptibility

Our findings were compared with those reported from prior studies through forest plots using fixed and random effect models (Figure 4). The effects observed for rs61735794 and rs75603675 differ from those reported in earlier studies (Figures 4A, B). In summary, the forest plots indicate that these two polymorphisms had no significant association with SARS-CoV-2 infection susceptibility. In contrast, polymorphism rs4303795 (Figure 4C) exhibited a significant association with SARS-CoV-2 infection under both dominant (OR = 1.80; 95%CI = 1.39–2.33) and recessive models, although the latter was marginal and exhibited high heterogeneity (I2 = 64%). SNP rs8134378 also showed a significant association (OR = 2.62; 95%CI = 1.45–4.74) under the dominant model (Figure 4D). Additional meta-analyses were conducted using the other TMPRSS2 genetic variants; however, no associations were found (Supplementary Figures S2-5).

Figure 4
www.frontiersin.org

Figure 4. Forest plot obtained from the fixed effect model showing the risk contribution under the dominant and recessive models (when possible) in the four TMPRSS2 polymorphisms with risk association: (A) rs61735794, (B) rs75603675, (C) rs4303795 and (D) rs8134378.

3.4 Other polymorphisms

Although previous studies have identified certain polymorphisms in the ACE2, ADAM17, FURIN, IFITM3, and VDR genes associated with infection susceptibility to SARS-CoV-2, our findings did not reveal any such associations (data not shown).

4 Discussion

COVID-19 results from the interplay of numerous genetic variants together with pre-existing medical comorbidities, individual precautions, hygiene practices, and even government-imposed restrictions (Hubacek, 2021; Sutton et al., 20 22). In particular, the risk of COVID-19 is increased for individuals living with comorbidities such as cardiometabolic and lung and kidney diseases (Camelo et al., 2024). Obesity and diabetes are significant risk factors that are prevalent within the Mexican population (Li et al., 2023). COVID-19 complications could increase in persons with cancer, immunosuppression, malnutrition and its consequences (Camelo et al., 2024; Villapalos-García et al., 2022). Further, male sex and advanced age (>65 years) are considered risk factors for a severe course (Lott et al., 2022). Lifestyle factors also contribute to susceptibility; cigarette smoking and avoiding hand-washing have been considered SARS-CoV-2 infection risk factors (Liu et al., 2023; Lott et al., 2022). In addition to the previous factors, the genetic ones are also relevant; individual genetic variability and gene interactions play a critical role in the differences observed in susceptibility to this and other infectious diseases. Host genetics has been one of the most accredited factors contributing to COVID-19 due to its association with susceptibility and clinical course (Brest et al., 2020). Several genes were studied during the pandemic for their association with COVID-19 clinical manifestations and outcomes, particularly those related to viral entry mechanisms (Yamamoto et al., 2021). Among these, TMPRSS2 have been widely studied due to its role in SARS-CoV-2 membrane fusion to the host cell. Some gene polymorphisms seem to contribute to susceptibility and severity in some populations but not others, demonstrating that genetic background may play a role in COVID-19 development (Gupta and Misra, 2020). Latin American populations have experienced various demographic events over the past 500 years, providing an ideal context to investigate whether the characterisation of previously described gene variants is related to the susceptibility of infection and clinical manifestations and if this could be due to the ancestral background (Gomez et al., 2021). In the present study, 24 single nucleotide polymorphisms located on ACE2, ADAM17, FURIN, IFITM3, TMPRSS2, and VDR genes were characterised in 241 adults infected with SARS-CoV-2 (cases), along with their respective reference population paired by sex. However, because our cases and reference population were sampled at different times and came to BIMODI for different reasons, genetic background and environmental exposures could not be identical for both groups. The results were compared with findings from other studies using meta-analyses and multidimensional scale plots.

4.1 TMPRSS2 polymorphisms association with SARS-CoV-2 infection susceptibility

Despite numerous studies demonstrating the role of TMPRSS2 in the development of SARS-CoV-2, the current findings enhance the understanding of how these gene polymorphisms influence susceptibility to infection. Out of the seven analysed polymorphisms, three (rs75603675, rs4303795, and rs8134378) presented a significant association. Similar results have been reported for rs75603675 in another Mexican sample, as well as in Italian, Russian, and Spanish populations, thereby reinforcing our findings (Martínez-Gomez et al., 2024; Calcagnile et al., 2024; Minashkin et al., 2022; Torres-Fuentes et al., 2021; Villapalos-García et al., 2022). Besides its role in infection susceptibility, rs75603675 has been involved in symptomatology, clinical manifestations, severity, and mortality (Martínez-Gomez et al., 2024; Minashkin et al., 2022; Torres-Fuentes et al., 2021; Villapalos-García et al., 2022). TMPRSS2 is primarily expressed in the lungs, thyroid, and small intestinal epithelia, among other tissues. Different expression patterns of TMPRSS2 have been reported, mainly in lung tissue, the primary site of infection (Irham et al., 2020). Thyroid hormone levels play a role in coagulation, which is one of the leading causes of death associated with COVID-19; antithrombin, a coagulation regulator, inhibits TMPRSS2, thereby reducing the likelihood of coronavirus infection (Wettstein et al., 2023). Furthermore, TMPRSS2 has shown significantly higher expression in duodenum tissue from SARS-CoV-2 infected patients than uninfected individuals, which has been associated with gastrointestinal symptoms (Lin et al., 2023).

TMPRSS2 structure could be modified by missense variants such as rs75603675, whose allelic substitution (c.23C > A) provokes an amino acid change (p.Gly8Val). Even though both amino acids are nonpolar, there are significant differences between them. Glycine is the smallest amino acid and the only one with an achiral carbon which could provoke structural changes. In-silico studies have revealed that the substitution of Gly by Val, along with the modifications in other SNPs, might affect the N-terminal ends and, in turn, TMPRSS2 folding (Calcagnile et al., 2024; Paniri et al., 2021; Saih et al., 2021). The Human Splicing Finder (HSF), an in silico splice sites tool, predicted a broken donor splice site caused by substituting one allele with another in rs75603675 (Paniri et al., 2021). Furthermore, the number of hydrogen bonds is also different: ≈35 in TMPRSS2-Gly8 and more than 40 in TMPRSS2-Val8, conferring greater stability. In its ancestral form (rs75603675-C-allele-p.Gly), the endocytic signal is eclipsed by tyrosine at position 26, which partially covers it, causing the endocytic signal to fall in a flexible region (Minashkin et al., 2022). In contrast, when the derivate allele (rs75603675-A-allele-p.Val) is present, the endocytosis signal is more accessible, which translates to a higher susceptibility of the SARS-CoV-2 infection, supporting our findings as well as those of other research groups (Calcagnile et al., 2024). Similar findings have been reported for the intron variant rs8134378, which is in linkage disequilibrium with rs75603675 (Tug et al., 2024).

Polymorphism rs4303795, located in the promoter region, could modify TMPRSS2 expression. A previous report suggested that the derivative allele (rs4303795-G) could create binding sites for the Hepatocyte Nuclear Factor 4 (HNF4) and the Kidney, Ischaemia, and Developmentally-Regulated Protein 3 (KID3) (Vargas-Alarcon et al., 2020). Both HNF4 and KID3 orchestrate various transcriptional programs in different organs, and their dysregulation is associated with chronic inflammatory states, which are central to COVID-19 symptomatology (Vemuri et al., 2023; Jung et al., 2017). Our findings revealed that the frequency of the derivative allele was relatively close (0.434) to that reported in a prior study (0.495) within the Iranian population (Rokni et al., 2022).

Increased endocytosis, or changes in gene expression associated with risk alleles, may explain some of the specific characteristics of haplotype frequencies. In this context, the haplotypes that carried the derivate alleles in rs75603675-A and rs4303795-G were significantly more prevalent in the case group compared to the reference one. As previously mentioned, the spatial modifications provoked by the derivative allele could enhance the endocytosis signal, increasing susceptibility to infection (Calcagnile et al., 2024). Thus, the risk association of these and other polymorphisms in TMPRSS2 is not surprising, given its role in SARS-CoV-2 entry into the host cells and other mechanisms previously mentioned.

The significance of our findings regarding rs4303795 and rs8134378, along with the results from other research groups, was reinforced by the meta-analysis (Tug et al., 2024; Vargas-Alarcon et al., 2020; Rokni et al., 2022). However, some controversies about rs75603675 emerged: our results proposed the derivative allele -A- as the riskier one, while other studies have proposed that the ancestral allele -C- is riskier (Villapalos-García et al., 2022; Rokni et al., 2022). Nevertheless, haplotype analyses indicated that both alleles seem to contribute to infection, highlighting the importance of allele combinations and the remarkable function of TMPRSS2 in SARS-CoV-2 infection susceptibility (Rokni et al., 2022). The role of allele frequency distribution is a critical point when haplotypes are constructed. Thus, the discrepancies reported among populations warrant further discussion.

4.2 Comparison of TMPRSS2 polymorphisms among populations

The fact that the case group is genetically four times closer to EUR than the reference group (concerning TMPRSS2 polymorphisms) allows us to speculate that those Mexican Mestizos that have inherited TMPRSS2 variants from a European ancestor are genetically more susceptible to SARS-Cov-2 infection than those with TMPRSS2 variants coming from another parental population. This suggestion came about from the MDS plot (Figure 3C), in which EUR and cases were set to the right of the first dimension, while MXL and the reference group are to the left. Nevertheless, the differences in the allele frequencies between Europeans and the studied population could be due to different demographic events that the Mexican Mestizo population experienced in recent history. On one hand, there was at least one population bottleneck during the Spanish conquest (Gomez et al., 2021). On the other, there was a founder effect coming from the southern part of the Iberian Peninsula; a particular diversity melting pot (Alvarez-Topete et al., 2024).

Several studies, including the present one, have demonstrated that these three SNPs (rs75603675, rs4303795, and rs8134378) exhibit the highest frequencies of risk alleles within European populations (Paniri et al., 2021). Therefore, when haplotype frequencies were analysed, SARS-CoV-2 infection risk became more evident, as observed in other studies (Rokni et al., 2022). Disparities in susceptibility and mortality rates have been reported across different ethnicities; Afro-descendants, Native Americans, Asians and Latinos have shown higher susceptibility rates compared to non-Hispanic whites (Sutton et al., 2022). Nonetheless, the European populations were severely affected, even more than Asians, with Italy and Spain ranking as the two worst-hit countries within the European Community (Ceylan, 2020). Although the Mexican Mestizo population is admixed and presents heterogeneous ancestry, high proportions of European lineages have been reported (Alvarez-Topete et al., 2024; Gomez et al., 2021; Santana et al., 2014). In addition, European countries have exhibited the highest frequencies in terms of TMPRSS2 missense mutations (Zarubin et al., 2020). Such variants were almost five times more frequent among Southern Europeans (where the Mexican ancestral connection is located) than among East Asians, the second Mexican major ancestry due to its relation to Native Americans, where the missense mutations were scant (frequency ≤0.0001) (Zarubin et al., 2020). As mentioned before, certain allelic variations have been associated with elevated transcription (Barash et al., 2020). Likewise, TMPRSS2 gene variants such as rs2070788, rs464397, rs469390, and rs383510 could affect expression, particularly in lung tissue (Irham et al., 2020). Nonetheless, several SNPs around the TMPRSS2 polymorphisms likely presented LD, suggesting that other SNPs could also modify its expression. Europeans have the highest frequencies of TMPRSS2-upregulating variants, whereas Asians have the lowest ones (Irham et al., 2020). Regarding American ancestry, it presented higher frequencies than Asians and lower than Europeans, which could explain our findings. It is important to note that the data used regarding the Americas is represented only by Latino populations (1KGP; https://www.internationalgenome.org/).

When comparing the minor allele frequency (MAF) in rs75603675, the highest frequency has been reported in EUR (0.405) and the lowest was in EAS (0.017). Our reference group showed MAF = 0.200, possibly reflecting the recent admixture 500 years ago (Shelton et al., 2021; Gomez et al., 2021). Queretaro state and other north-central regions of Mexico exhibit higher proportions of European-derived ancestry compared to the southern regions (Gomez et al., 2021; Santana et al., 2014; Sohail et al., 2023). This may explain the high frequencies of the haplotypes AGA, AGG, and AAG found among the case group, which are also prevalent in Europeans. This suggests that such ancestry could confer a certain susceptibility to SARS-CoV-2 infection, as shown during the pandemic (Ceylan, 2020). Indeed, rs75603675 has been identified as a predictor of COVID-19 severity, and Polyphen-2 has conferred a high score (0.815 out of one), suggesting a possibly hazardous role (Villapalos-García et al., 2022; Paniri et al., 2021). Consequently, in populations with low European ancestry (i.e., Iranian and Vietnamese), no contribution from rs75603675 has been reported (Rokni et al., 2022; Nhung et al., 2022). In the Spanish population from Madrid, the rs75603675-C allele has shown an association with COVID-19 severity (Villapalos-García et al., 2022). As mentioned before, the allele frequency distribution of Mexican Mestizos varies in comparison to that of Spanish.

About the other three TMRSS2 SNPs (rs456298, rs2070788, and rs12329760) for which we did not find any association, the only result published thus far about rs456298 was also conducted in the Mexican Mestizo population (Posadas-Sanchez et al., 2022). In that study, the A-allele appeared as the risk allele with significant association using several models (i.e., additive, co-dominant, and recessive), although we did not find any association. These discrepancies could be associated with the sample size (three times smaller in our study) and also with the reference sample size (almost half the size of the cases group in the previous study) (Posadas-Sanchez et al., 2022). When wanting to detect allele effects, the sizes of case and reference groups are assumed to be similar (Smith and Day, 1984). In the former study, the reference group was obtained from medical staff, and patients were mixed from several hospitals, which could cause a selection bias (Posadas-Sanchez et al., 2022). Because of the recent formation of the Mexican Mestizo population, a homogeneous genetic architecture is not present (Santana et al., 2014; Noris et al., 2012). Thus, the difference found between the two rs456298 studies could be an effect of the population stratification that has been previously reported (Camacho-Mejorado et al., 2015).

Comparable to the results of the present study, no contribution to COVID-19 symptomatology has been found for rs2070788 and rs12329760 in both Mexican Mestizos and Spanish populations (Martínez-Gomez et al., 2024; Fernandez-de-las-Peñas et al., 2022). Similar findings have been reported regarding rs12329760 in Brazilians (Caldeira de Andrade et al., 2022). By contrast, rs2070788 has been linked to an increased risk of death and comorbidities in Brazilians and among symptomatic and intensive care unit patients in Türkiye (Tug et al., 2024; Caldeira de Andrade et al., 2022). While rs12329760 has shown different distributions between cases and the reference group, it has been associated with COVID-19 susceptibility and mortality in Iranian populations (Rokni et al., 2022). Our results should be interpreted cautiously due to the potential of linkage disequilibrium among these three SNPs or differences in their allele frequencies across the studied populations. It is important to note that our study is focused on infection susceptibility, while others have focused on illness severity and progression.

4.3 ACE2, ADAM17, FURIN, IFITM3 and VDR did not show contribution to SARS CoV-2 infection susceptibility

The absence of association with SARS-CoV-2 infection susceptibility by polymorphisms studied on ACE2, ADAM17, FURIN, IFITM3, and VDR remains controversial in light of previous reports. In this setting, various factors could contribute to this discrepancy. First, most of the polymorphisms analysed in this study have been linked more closely to disease severity, progression and complications rather than to infection susceptibility (Coto et al., 2022; Pandey et al., 2024; Schönfelder et al., 2021; Barbosa-Rodrigues et al., 2023). VDR, FURIN, and ADAM17 polymorphisms have been related to cytokine storm and, in turn, to illness severity and its subsequent outcome (Coto et al., 2022; Balzanelli et al., 2022; Da Silva Correa da Ronda et al., 2024; Pan et al., 2023). Second, these controversies have also been reported across different geographic regions and even within the same country. IFITM3 variants have not shown any contribution to COVID-19 in European, Middle Eastern, and Asian populations (Ferreira de Araujo et al., 2022; Li et al., 2022; Dobrijevic et al., 2022; Ren et al., 2023). In contrast, this gene has been linked to disease severity in other populations (Jafarpour et al., 2021; Benmansour et al., 2024). These discrepancies suggest that the influence of genetic architecture, particularly population stratification, might be the primary source of bias in genetic association studies (Wacholder et al., 2000).

ACE2 has been considered a cornerstone in COVID-19 development and other respiratory diseases, although these findings have not been consistent. Studies carried out in German and Spanish populations (rs2285666 and rs2074192) have shown a significant association between COVID-19 and post-COVID symptoms (Fernandez-de-las-Peñas et al., 2022; Wacharapol et al., 2022). In contrast, studies from Spain, Türkiye and those presented in this document did not find any association (Torres-Fuentes et al., 2021; Wacharapol et al., 2022). The sample size and the genetic structure of the population could influence the findings mentioned, among other potential explanations for these discrepancies. Additionally, the present study was focused on the susceptibility to infection with SARS-CoV-2 rather than on the severity of COVID-19 symptoms. Therefore, it is likely that our findings could be biased in this context.

4.4 Strengths and limitations

One of the strengths of the present study is our reference population. This population was randomly obtained from samples taken before the SARS-CoV-2 pandemic, accurately reflecting the genetic architecture of the population that comes to the laboratory and minimising certain biases. However, such a population may also represent a weakness, as our cases were not strictly drawn from the same population as this reference. Also, a limitation of our study is that it did not account for comorbidities since BIMODI’s protocols before the pandemic did not include a questionary about comorbidities. Additionally, the absence of data regarding disease severity, symptomatology, and close contact with COVID-19 individuals also represent limitations; therefore, our results should be interpreted in light of these constraints.

5 Conclusion

It is likely that in addition to comorbidities and lifestyle, genetic factors impact SARS-CoV-2 infection susceptibility; to study this, the ancestral background has to be considered, particularly in admixed young populations. We found a significant association of three SNPs (separated and in haplotypes) in the TMPRSS2 gene with SARS-CoV-2 infection susceptibility in Mexican Mestizos and the possible contribution of European ancestry in the heritage of the risk haplotypes. Further studies should be carried out with larger sample sizes and should consider other factors such as comorbidities, individual precautions, and hygiene practices, among others, to support our findings.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Ethics statement

The studies involving humans were approved by the Internal Ethics Committe from BIMODI/BMD-DI-2020-01. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

RM: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – original draft. CD: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – review and editing. GN: Conceptualization, Data curation, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review and editing. MP-P: Data curation, Methodology, Writing – review and editing. CS: Conceptualization, Data curation, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review and editing. RG: Conceptualization, Data curation, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review and editing.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Acknowledgments

We would like to extend our gratitude to the women and men who contributed to this study and to the National Council of Science and Technology (CONACYT acronym in Spanish) for supporting Cinthia L. Dionicio postdoctoral fellowship. We also thank PhD. Luisa E. Torres-Sánchez for her invaluable assistance in reviewing the epidemiological questionnaire. Finally, we express our appreciation to the BIMODI team for their participation in this project during the pandemic.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2025.1558189/full#supplementary-material

References

Alvarez-Topete, E., Torres-Sanchez, L. E., Hernandez-Tobias, E. A., Veliz, D., Hernandez-Perez, J. G., Lopez-Gonzalez, M. L., et al. (2024). Circum-Mediterranean influence in the Y-chromosome lineages associated with prostate cancer in Mexican men: a Converso heritage founder effect? PLoS One 19 (8), e0308092. doi:10.1371/journal.pone.0308092

PubMed Abstract | CrossRef Full Text | Google Scholar

Balzanelli, M. G., Distratis, P., Lazzaro, R., Pham, V. H., Tran, T. C., Dipalma, G., et al. (2022). Analysis of gene single nucleotide polymorphisms in COVID-19 disease highlighting the susceptibility and the severity towards the infection. Diagn. (Basel) 12 (11), 2824. doi:10.3390/diagnostics12112824

PubMed Abstract | CrossRef Full Text | Google Scholar

Barash, A., Machluf, Y., Ariel, I., and Dekel, Y. (2020). The pursuit of COVID-19 biomarkers: putting the spotlight on ACE2 and TMPRSS2 regulatory sequences, Front. Med., 7: 582793. doi:10.3389/fmed.2020.582793

PubMed Abstract | CrossRef Full Text | Google Scholar

Barbosa-Rodrigues, F. B., da Silva, R., Ferreira-Dos Santos, E., de Brito, M. T. F., Soares da Silva, A. L., de Meira-Leite, M., et al. (2023). Association of polymorphisms of IL-6 pathway genes (IL6, IL6R and IL6ST) with COVID-19 severity in an amazonian population. Viruses 15 (5), 1197. doi:10.3390/v15051197

PubMed Abstract | CrossRef Full Text | Google Scholar

Belkhir, K., Borsa, P., Chikhi, L., Raufaste, N., and Bonhomme, F. (2004). “GENETIX 4.05, logiciel sous Windows TM pour la genetique des populations,” in Laboratoire genome, populations, interactions, CNRS UMR 5000 (France: Universite de Montpellier II).

Google Scholar

Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289–300. doi:10.1111/j.2517-6161.1995.tb02031.x

CrossRef Full Text | Google Scholar

Benmansour, R., Tagajdid, M. R., Hamzaoui, H., Fjouji, S., Doghmi, N., Houba, A., et al. (2024). TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco. Int. J. Immunopathol. Pharmacol. 38, 3946320241257241. doi:10.1177/03946320241257241

PubMed Abstract | CrossRef Full Text | Google Scholar

Brest, P., Refae, S., Mograbi, B., Hofman, P., and Milano, G. (2020). Host polymorphisms may impact SARS-CoV-2 infectivity. Trends Genet. 36 (11), 813–815. doi:10.1016/j.tig.2020.08.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Calcagnile, M., Damiano, F., Lobreglio, G., Siculella, L., Bozzetti, M. P., Forgez, P., et al. (2024). In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: implication for SARS-cov-2 entry into host cells and susceptibility to COVID-19. Biochimie 225, 89–98. doi:10.1016/j.biochi.2024.05.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Caldeira de Andrade, C., Paulo-Silva, A. T., Silva-Vasconcelos, L. R., Silveira-Oliveira, P. R., Freire de Souza, C. D., Costa-Armstrong, A., et al. (2022). A polymorphism in the TMPRSS2 gene increases the risk of death in older patients hospitalized with COVID-19. Viruses 14 (11), 2557. doi:10.3390/v14112557

PubMed Abstract | CrossRef Full Text | Google Scholar

Camacho-Mejorado, R., Noris, G., Santana, C., Magaña, J. J., Majluf-Cruz, A., Arellano-Galindo, J., et al. (2015). Interethnic variation of the MMP-9 microsatellite in Amerindian and Mexican Mestizo populations: considerations for genetic association studies. Genet. Mol. Res. 14 (1), 2929–2939. doi:10.4238/2015.March.31.24

PubMed Abstract | CrossRef Full Text | Google Scholar

Camelo, A. L. M., Obando, H. R. Z., Rocha, I., Dias, A. C., Mesquita, A. S., and Simionato, A. V. C. (2024). COVID-19 and comorbidities: what has been unveiled by metabolomics? Metabolites 14 (4), 195. doi:10.3390/metabo14040195

PubMed Abstract | CrossRef Full Text | Google Scholar

Ceylan, Z. (2020). Estimation of COVID-19 prevalence in Italy, Spain, and France. Sci. Total Environ. 10 (729), 138817. doi:10.1016/j.scitotenv.2020.138817

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng, Z., Zhou, J., Kai-Wang, K., Chu, H., Li, C., Wang, D., et al. (2015). Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza. 212(8):1214–1221. doi:10.1093/infdis/jiv246

PubMed Abstract | CrossRef Full Text | Google Scholar

Coto, E., Albaiceta, G. M., Amado-Rodriguez, L., Garcia-Clemente, M., Cuesta-Llavona, E., Vazquez-Coto, D., et al. (2022). FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19. J. Med. Virol. 94 (8), 3589–3595. doi:10.1002/jmv.27748

PubMed Abstract | CrossRef Full Text | Google Scholar

Da Silva Correa da Ronda, C. R., Berlofa, V. M., Tiemi Siguemoto, J., Motta Neri, C., Lopo de Abreu, M. C., da Souza Nicoletti, A., et al. (2024). Single-nucleotide polymorphisms related to vitamin D metabolism and severity or mortality of COVID-19: a systematic review and meta-analysis. Gene 906, 148236. doi:10.1016/j.gene.2024.148236

PubMed Abstract | CrossRef Full Text | Google Scholar

David, A., Parkinson, N., Peacock, T., Pairo-Castineira, E., Khanna, T., Cobat, A., et al. (2022). A common TMPRSS2 variant has a protective effect against severe COVID-19. Curr. Res. Transl. Med. 70 (2), 103333. doi:10.1016/j.retram.2022.103333

PubMed Abstract | CrossRef Full Text | Google Scholar

Dobrijevic, Z., Robajac, D., Gligorijevic, N., Šunderic, M., Penezic, A., Miljus, G., et al. (2022). The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity: a systematic review and meta-analysis. EXCLI J. 21, 818–839. doi:10.17179/excli2022-4976

PubMed Abstract | CrossRef Full Text | Google Scholar

Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., et al. (2020). COVID-19 and comorbidities: deleterious impact on infected patients. J. Infect. Public Health 13 (12), 1833–1839. doi:10.1016/j.jiph.2020.07.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Excoffier, L., and Lischer, H. (2010). Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour. 10 (3), 564–567. doi:10.1111/j.1755-0998.2010.02847.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Farooqi, R., Kooner, J. S., and Zhang, W. (2023). Associations between polygenic risk score and Covid-19 susceptibility and severity across ethnic groups: UK Biobank analysis. BMC Med. Genomics 16 (1), 150. doi:10.1186/s12920-023-01584-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Fernandez-de-las Peñas, C., Arendt-Nielsen, L., Diaz-Gil, G., Gomez-Esquer, F., Gil-Crujera, A., Gomez-Sanchez, S. M., et al. (2022). Genetic association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) polymorphisms with post-COVID symptoms in previously hospitalized COVID-19 survivors. Genes. (Basel) 13 (11), 1935. doi:10.3390/genes13111935

PubMed Abstract | CrossRef Full Text | Google Scholar

Ferreira de Araujo, J. L., Menezes, D., Santa de Aguilar, R., and de Souza, R. P. (2022). IFITM3, FURIN, ACE1, and TNF-α genetic association with COVID-19 outcomes: systematic review and meta-analysis, 13.775246

Google Scholar

Gomez, R., Schurr, T. G., and Meraz-Ríos, M. A. (2021). “Diversity of Mexican paternal lineages reflects evidence of migration and 500 Years of admixture,” in Human migration: biocultural perspectives. Editors M. L. Muñoz-Moreno, and M. H. Crawford (New York, NY: Oxford University Press), 139–152.

Google Scholar

Gomez-Mesa, J. E., Galindo-Coral, S., Montes, M. A., Alarco, W., Barisani, J. L., Magaña, A., et al. (2021). Latin-American registry of cardiovascular disease and COVID-19: rationale and design of the CARDIO COVID 19-20 registry. Glob. Heart 16 (1), 14. doi:10.5334/gh.925

PubMed Abstract | CrossRef Full Text | Google Scholar

Gupta, R., and Misra, A. (2020). COVID19 in South Asians/Asian Indians: heterogeneity of data and implications for pathophysiology and research. Diabetes Res. Clin. Pract. 165, 108267. doi:10.1016/j.diabres.2020.108267

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, P., Zhang, L., Tan, Y., and Chen, S. (2023). Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl. Neurodegener. 12 (1), 5. doi:10.1186/s40035-023-00337-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Hubacek, J. A. (2021). Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression. Physiol. Res. 70 (S2), S125–S134. doi:10.33549/physiolres.934730

PubMed Abstract | CrossRef Full Text | Google Scholar

Irham, L. M., Chou, W., Calkins, M. J., Adikusuma, W., Hsieh, S., and Chang, W. (2020). Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochem. Biophys. Res. Commun. 529 (2), 263–269. doi:10.1016/j.bbrc.2020.05.179

PubMed Abstract | CrossRef Full Text | Google Scholar

Ishak, A., Mehendale, M., AlRawashdeh, M. M., Sestacovschi, C., Sharath, M., Pandav, K., et al. (2022). The association of COVID-19 severity and susceptibility and genetic risk factors: a systematic review of the literature. Gene 836, 146674. doi:10.1016/j.gene.2022.146674

PubMed Abstract | CrossRef Full Text | Google Scholar

Jafarpour, R., Pashangzadeh, S., and Dowran, R. (2021). Host factors: implications in immunopathogenesis of COVID-19. Pathol. Res. Pract. 228, 153647. doi:10.1016/j.prp.2021.153647

PubMed Abstract | CrossRef Full Text | Google Scholar

Jung, D., Xu, Y., and Sun, Z. (2017). Induction of anti-aging gene klotho with a small chemical compound that demethylates CpG islands. Oncotarget 8 (29), 46745–46755. doi:10.18632/oncotarget.18608

PubMed Abstract | CrossRef Full Text | Google Scholar

Leigh, J., and Bryant, D. (2015). Popart: full-feature software for haplotype network construction. Methods Ecol. Evol. 6, 1110–1116. doi:10.1111/2041-210x.12410

CrossRef Full Text | Google Scholar

Li, C., Islam, N., Gutierrez, J. P., Gutierrez-Barreto, S. E., Castañeda Prado, A., Moolenaar, R., et al. (2023). Associations of diabetes, hypertension and obesity with COVID-19 mortality: a systematic review and meta-analysis. BMJ Glob. Health 8 (12), e012581. doi:10.1136/bmjgh-2023-012581

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, Y., Wei, L., He, L., Sun, J., and Liu, N. (2022). Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: a meta-analysis. J. Infect. 84 (6), 825–833. doi:10.1016/j.jinf.2022.04.029

PubMed Abstract | CrossRef Full Text | Google Scholar

Lin, L., Zeng, F., Mai, L., Gao, M., Fang, Z., Wu, B., et al. (2023). Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association with gastrointestinal symptoms. Am. J. Med. Sci. 366 (6), 430–437. doi:10.1016/j.amjms.2023.08.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, W., Zhao, Y., Fan, J., Shen, J., Tang, H., Tang, W., et al. (2023). Smoke and spike: benzo[a]pyrene enhances SARS-CoV-2 infection by boosting nr4a2-induced ACE2 and TMPRSS2 expression. Adv. Sci. (Weinh) 10 (26), e2300834. doi:10.1002/advs.202300834

PubMed Abstract | CrossRef Full Text | Google Scholar

Lott, N., Gebhard, C. E., Bengs, S., Haider, A., Kuster, G. M., Regitz-Zagrosek, V., et al. (2022). Sex hormones in SARS-CoV-2 susceptibility: key players or confounders? Nat. Rev. Endocrinol. 19 (4), 217–231. doi:10.1038/s41574-022-00780-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Martínez-Gomez, L. E., Martinez-Armenta, C., Tusie-Luna, T., Vazquez-Cardenas, P., Vidal-Vazquez, R. P., Ramirez-Hinojosa, J. P., et al. (2024). The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes. Front. Immunol. 15, 1335963. doi:10.3389/fimmu.2024.1335963

PubMed Abstract | CrossRef Full Text | Google Scholar

Martorell-Marugan, J., Toro-Dominguez, D., Alarcon-Riquelme, M. E., and Carmona-Saez, P. (2017). MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinforma. 18, 563. doi:10.1186/s12859-017-1990-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Minashkin, M. M., Grigortsevich, N. Y., Kamaeva, A. S., Barzanova, V. V., Traspov, A. A., Godkov, M. A., et al. (2022). The role of genetic factors in the development of acute respiratory viral infection COVID-19: predicting severe course and outcomes. Biomedicines 10 (3), 549. doi:10.3390/biomedicines10030549

PubMed Abstract | CrossRef Full Text | Google Scholar

Nhung, V. P., Ton, N. D., Ngoc, T. T. B., Thuong, M. T. H., Hai, N. T. T., Oanh, K. T. P., et al. (2022). Host genetic risk factors associated with COVID-19 susceptibility and severity in Vietnamese. Genes. (Basel) 13 (10), 1884. doi:10.3390/genes13101884

PubMed Abstract | CrossRef Full Text | Google Scholar

Niemi, M. E., Daly, M. J., and Ganna, A. (2022). The human genetic epidemiology of COVID-19. Nat. Rev. Genet. 23 (9), 533–546. doi:10.1038/s41576-022-00478-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Noris, G., Santana, C., Meraz-Rios, M. A., Muñoz, M. L., Majluf-Cruz, A., Magaña, J. J., et al. (2012). Mexican mestizo population sub-structure: effects on genetic and forensic statistical parameters. Mol. Biol. Rep. 39 (12), 10139–10156. doi:10.1007/s11033-012-1888-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Pan, M., Goncalves, I., Edsfeldt, A., Sun, J., and Swärd, P. (2023). Genetic predisposition to elevated levels of circulating ADAM17 is associated with the risk of severe COVID-19. Int. J. Mol. Sci. 24 (21), 15879. doi:10.3390/ijms242115879

PubMed Abstract | CrossRef Full Text | Google Scholar

Pandey, R. K., Srivastava, A., Mishra, R. K., Singh, P. P., and Chaubey, G. (2024). Novel genetic association of the Furin gene polymorphism rs1981458 with COVID-19 severity among Indian populations. Sci. Rep. 14 (1), 7822. doi:10.1038/s41598-024-54607-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Paniri, A., Hosseini, M. M., and Akhavan-Niaki, H. (2021). First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. J. Biomol. Struct. Dyn. 39 (10), 3576–3593. doi:10.1080/07391102.2020.1767690

PubMed Abstract | CrossRef Full Text | Google Scholar

Posadas-Sanchez, R., Fragoso, J. M., Sanchez-Muñoz, F., Rojas-Velasco, G., Ramirez-Bello, J., Lopez-Reyes, A., et al. (2022). Association of the transmembrane serine protease-2 (TMPRSS2) polymorphisms with COVID-19. Viruses 14 (9), 1976. doi:10.3390/v14091976

PubMed Abstract | CrossRef Full Text | Google Scholar

Ren, H., Lin, Y., Huang, L., Xu, W., Luo, D., and Zhang, C. (2023). Association of genetic polymorphisms with COVID-19 infection and outcomes: an updated meta-analysis based on 62 studies. Heliyon 10 (1), e23662. doi:10.1016/j.heliyon.2023.e23662

PubMed Abstract | CrossRef Full Text | Google Scholar

Rokni, M., Nia, M. H., Sarhadi, M., Mirinejad, S., Sargazi, S., Moudi, M., et al. (2022). Association of TMPRSS2 gene polymorphisms with COVID-19 severity and mortality: a case-control study with computational analyses. Appl. Biochem. Biotechnol. 194 (8), 3507–3526. doi:10.1007/s12010-022-03885-w

PubMed Abstract | CrossRef Full Text | Google Scholar

Saih, A., Bouqdayr, M., Baba, H., Hamdi, S., Moussamih, S., Bennani, H., et al. (2021). Computational analysis of missense variants in the human transmembrane protease serine 2 (TMPRSS2) and SARS-CoV-2. Biomed. Res. Int. 2021, 9982729. doi:10.1155/2021/9982729

PubMed Abstract | CrossRef Full Text | Google Scholar

Santana, C., Noris, G., Meraz-Ríos, M. A., Magaña, J. J., Calderon-Aranda, E. S., Muñoz, M. L., et al. (2014). Genetic analysis of 17 Y-STRs in a mestizo population from the Central Valley of Mexico. Hum. Biol. 86 (4), 289–312. doi:10.13110/humanbiology.86.4.0289

PubMed Abstract | CrossRef Full Text | Google Scholar

Santoro, A., López Osorio, A., Williams, I., Wachs, M., Cejas, C., Havela, M., et al. (2022). Development and application of a dynamic transmission model of health systems' preparedness and response to COVID-19 in twenty-six Latin American and Caribbean countries. PLOS Glob. Public Health 2 (3), e0000186. doi:10.1371/journal.pgph.0000186

PubMed Abstract | CrossRef Full Text | Google Scholar

Schönfelder, K., Breuckmann, k, Elsner, C., Dittmer, U., Fistera, D., Herbstreit, F., et al. (2021). The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19. Cytokine 142, 155492. doi:10.1016/j.cyto.2021.155492

PubMed Abstract | CrossRef Full Text | Google Scholar

Shelton, J. F., Shastri, A. J., Ye, C., Weldon, C. H., Filshtein-Sonmez, T., Coker, D., et al. (2021). Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet. 53 (6), 801–808. doi:10.1038/s41588-021-00854-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Smith, P. G., and Day, N. E. (1984). The design of case-control studies: the influence of confounding and interaction effects. Clin. Trial 13 (3), 356–365. doi:10.1093/ije/13.3.356

PubMed Abstract | CrossRef Full Text | Google Scholar

Sohail, M., Palma-Martinez, M. J., Chong, A., Quinto-Cortes, C., Barberena-Jonas, C., Medina-Muñoz, S. G., et al. (2023). Mexican Biobank advances population and medical genomics of diverse ancestries. Nature 622 (7984), 775–783. doi:10.1038/s41586-023-06560-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Sutton, N. R., Robinson-Lane, S. G., Yeow, R. Y., Chubb, H. A., Kim, T., and Chopra, V. (2022). Racial and ethnic variation in COVID-19 care, treatment, and outcomes: a retrospective cohort study from the MiCOVID-19 registry. PLoS One 17 (11), e0276806. doi:10.1371/journal.pone.0276806

PubMed Abstract | CrossRef Full Text | Google Scholar

Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Zhang, G., et al. (2023). SRplot: a free online platform for data visualization and graphing. PLoS One 18 (11), e0294236. doi:10.1371/journal.pone.0294236

PubMed Abstract | CrossRef Full Text | Google Scholar

Torres-Fuentes, L., Matias-Guiu, J., Hernandez-Lorenzo, L., Montero-Escribano, P., Pytel, V., Porta-Etessam, J., et al. (2021). ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. J. Med. Virol. 93 (2), 863–869. doi:10.1002/jmv.26319

CrossRef Full Text | Google Scholar

Tug, E., Fidan, I., Bozdayi, G., Yildirim, F., Tunccan, O., Lale, Z., et al. (2024). The relationship between the clinical course of SARS-CoV-2 infections and ACE2 and TMPRSS2 expression and polymorphisms. Adv. Clin. Exp. Med. 33 (1), 39–51. doi:10.17219/acem/163409

PubMed Abstract | CrossRef Full Text | Google Scholar

Vargas-Alarcon, G., Posadas-Sanchez, R., and Ramirez-Bello, J. (2020). Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Life Sci. 260, 118313. doi:10.1016/j.lfs.2020.118313

PubMed Abstract | CrossRef Full Text | Google Scholar

Vemuri, K., Hadi, S. H., Sladek, F. M., and Verzi, M. P. (2023). Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine. Front. Endocrinol. (Lausanne) 10 (14), 1232569. doi:10.3389/fendo.2023.1232569

CrossRef Full Text | Google Scholar

Viechtbauer, W. (2010). Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36 (3), 1–48. doi:10.18637/jss.v036.i03

CrossRef Full Text | Google Scholar

Villapalos-García, G., Zubiaur, P., Rivas-Duran, R., Campos-Norte, P., Arevalo-Roman, C., Fernandez-Rico, M., et al. (2022). Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life Sci. Alliance 5 (10), e202201396. doi:10.26508/lsa.202201396

PubMed Abstract | CrossRef Full Text | Google Scholar

Wacharapol, S., Jittikoon, J., Chaikledkaew, U., and Udomsinprasert, W. (2022). Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: a systematic review with meta-analysis. Rev. Med. Virol. 32 (4), e2323. doi:10.1002/rmv.2323

PubMed Abstract | CrossRef Full Text | Google Scholar

Wacholder, S., Rothman, N., and Caporaso, N. (2000). Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. 92 (14), 1151–1158. doi:10.1093/jnci/92.14.1151

PubMed Abstract | CrossRef Full Text | Google Scholar

Wettstein, L., Immenschuh, P., Weil, T., Conzelmann, C., Almeida-Hernandez, Y., Hoffmann, M., et al. (2023). Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection. J. Med. Virol. 95 (1), e28124. doi:10.1002/jmv.28124

PubMed Abstract | CrossRef Full Text | Google Scholar

World Health Organisation (2023). WHO Coronavirus disease (COVID-19). Available online at: https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-%28covid-19%29 (Accessed July 9, 2024).

Google Scholar

Yamamoto, N., Yamamoto, R., Ariumi, Y., Mizokami, M., Shimotohno, K., and Yoshikura, H. (2021). Does genetic predisposition contribute to the exacerbation of COVID-19 symptoms in individuals with comorbidities and explain the huge mortality disparity between the East and the west? Int. J. Mol. Sci. 22 (9), 5000. doi:10.3390/ijms22095000

PubMed Abstract | CrossRef Full Text | Google Scholar

Zarubin, A., Stepanov, V., Markov, A., Kolesnikov, N., Marusin, A., Khitrinskaya, I., et al. (2020). Structural variability, expression profile, and pharmacogenetic properties of TMPRSS2 gene as a potential target for COVID-19 therapy. Genes. (Basel) 12 (1), 19. doi:10.3390/genes12010019

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382 (8), 727–733. doi:10.1056/NEJMoa2001017

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: TMPRSS2, gene polymorphism, rs4303795, rs8134378, rs75603675, SARS-CoV-2 infection, COVID-19

Citation: Montero RI, Dionicio CL, Noris G, Piña-Pozas M, Santana C and Gómez R (2025) Genetic variants in TMPRSS2 influence SARS-CoV-2 infection susceptibility within Mexican Mestizos. Front. Genet. 16:1558189. doi: 10.3389/fgene.2025.1558189

Received: 09 January 2025; Accepted: 28 March 2025;
Published: 14 April 2025.

Edited by:

Zheng Jin Tu, Cleveland Clinic, United States

Reviewed by:

Jared C Roach, Institute for Systems Biology (ISB), United States
Jorge Aarón Rangel-Méndez, Universidad Autonoma de Yucatan, Mexico

Copyright © 2025 Montero, Dionicio, Noris, Piña-Pozas, Santana and Gómez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Carla Santana, Ymltb2RpQHlhaG9vLmNvbQ==; Rocío Gómez, bXJnb21lekBjaW52ZXN0YXYubXg=

These authors have contributed equally to this work

ORCID: Carla Santana, orcid.org/0000-0001-7866-3638

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.